Oct4 and Sox2 overexpression improves the proliferation and differentiation of bone mesenchymal stem cells in Xiaomeishan porcine

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 6067-6079

  Fan, Y X ^a   Gu, C H ^a   Zhang, Y L ^a   Zhong, B S ^a   Wang, L Z ^a   Zhou, Z R ^a   Wang, Z Y ^a   Jia, R X ^a   Wang, F ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bone mesenchymal stem cells; Oct4; Overexpression; Sox2; Xiaomeishan porcine

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OCT4 GENE; SOX2 GENE; SWINE;

ADIPOGENESIS; ALKALINE PHOSPHATASE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; HEK293 CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOGENESIS; SOXB1 TRANSCRIPTION FACTORS; SUS SCROFA;

EID: 84889589497     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.December.2.5     Document Type: Article

References (28)

1. Basu-Roy U, Ambrosetti D, Favaro R, Nicolis SK, et al. (2010). The transcription factor Sox2 is required for osteoblast self-renewal. Cell Death Differ. 17: 1345-1353.
2. Bosch P, Pratt SL and Stice SL (2006). Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol. Reprod. 74: 46-57.
3. Dailey L and Basilico C (2001). Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J. Cell Physiol. 186: 315-328.
4. Friedenstein AJ, Piatetzky-Shapiro II and Petrakova KV (1966). Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16: 381-390.
5. Go MJ, Takenaka C and Ohgushi H (2008). Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp. Cell Res. 314: 1147-1154.
6. Greco SJ, Liu K and Rameshwar P (2007). Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem. Cells 25: 3143-3154.
7. Griffin M, Iqbal SA and Bayat A (2011). Exploring the application of mesenchymal stem cells in bone repair and regeneration. J. Bone Joint Surg. Br. 93: 427-434.
8. Gurudutta GU, Satija NK, Singh VK, Verma YK, et al. (2012). Stem cell therapy: a novel & futuristic treatment modality for disaster injuries. Indian J. Med. Res. 135: 15-25.
9. Hayflick L (1965). The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614-636.
10. Horwitz EM, Gordon PL, Koo WK, Marx JC, et al. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. U. S. A. 99: 8932-8937.
11. Hu YL, Fu YH, Tabata Y and Gao JQ (2010). Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. J. Control Release 147: 154-162.
12. Imabayashi H, Mori T, Gojo S, Kiyono T, et al. (2003). Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis. Exp. Cell Res. 288: 35-50.
13. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
14. Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, et al. (2006). In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys Res. Commun. 340: 639-647.
15. Kuo YR, Goto S, Shih HS, Wang FS, et al. (2009). Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 87: 1769-1777.
16. Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, et al. (2007). Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int. J. Biochem. Cell Biol. 39: 2195-2214.
17. Masui S, Nakatake Y, Toyooka Y, Shimosato D, et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9: 625-635.
18. Nichols J, Zevnik B, Anastassiadis K, Niwa H, et al. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391.
19. Niwa H (2007). How is pluripotency determined and maintained? Development 134: 635-646.
20. Niwa H, Miyazaki J and Smith AG (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24: 372-376.
21. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
22. Poncelet AJ, Vercruysse J, Saliez A and Gianello P (2007). Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 83: 783-790.
23. Qin D, Li W, Zhang J and Pei D (2007). Direct generation of ES-like cells from unmodified mouse embryonic fibroblasts by Oct4/Sox2/Myc/Klf4. Cell Res. 17: 959-962.
24. Rodda DJ, Chew JL, Lim LH, Loh YH, et al. (2005). Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280: 24731-24737.
25. Takahashi K and Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
26. Wei X and Shen CY (2011). Transcriptional regulation of oct4 in human bone marrow mesenchymal stem cells. Stem Cells Dev. 20: 441-449.
27. Yang YJ, Qian HY, Huang J, Geng YJ, et al. (2008). Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur. Heart J. 29: 1578-1590.
28. Yoon DS, Kim YH, Jung HS, Paik S, et al. (2011). Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture. Cell Prolif. 44: 428-440.